Status:
COMPLETED
Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects
Lead Sponsor:
Pfizer
Conditions:
HCV
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
This is a phase 1 study to assess the routes of elimination of a single oral dose of \[14C\] PF-00868554 and to characterize the metabolic profile following single dose administration.
Eligibility Criteria
Inclusion
- Male, healthy volunteers.
Exclusion
- Females.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00823745
Start Date
January 1 2009
End Date
February 1 2009
Last Update
March 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Tacoma, Washington, United States, 98415